Chemoembolization
Sponsors
National Institutes of Health Clinical Center (CC), Shanghai Zhongshan Hospital, Erasmus Medical Center, University of Texas Southwestern Medical Center, Terumo Europe N.V.
Conditions
ChemoembolizationChemotherapy EffectColorectal NeoplasmsEndobronchial MetastasesHCCHepatic CancerHepatic Portal Vein Tumor InvasionHepatocellular Cancer
Phase 1
Safety and Pharmacokinetics of Treating Liver Cancer With Drug-Eluting Beads
TerminatedNCT01336985
Start: 2011-03-28End: 2011-03-28Updated: 2019-12-17
Chemoembolization of Non-resectable Non-metastatic Hepatocellular Carcinoma Using Embolization Microspheres
CompletedNCT02870010
Start: 2010-02-28Updated: 2016-08-19
Chemoembolization for Lung Tumors
CompletedNCT04200417
Start: 2019-12-13End: 2022-04-19Updated: 2025-05-16
Phase 2
Transarterial Chemoembolization Versus Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
TerminatedNCT02470533
Start: 2015-04-30End: 2020-04-30Target: 100Updated: 2021-01-27
LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma
TerminatedNCT02524119
Start: 2016-04-30End: 2020-09-30Updated: 2021-02-01
Phase 3
Unknown Phase
LifePearl-Doxo Pharmacokinetic (PK) Study
CompletedNCT02548780
Start: 2016-04-30End: 2019-10-18Updated: 2020-01-27
Microwave Ablation Combined With TACE in the Treatment of Unresectable Huge Hepatocellular Carcinoma Huge
NCT03277716
Start: 2017-12-01End: 2021-12-30Target: 100Updated: 2019-05-07
DC Bead LUMI (TM) Loaded With Doxorubicin for Intermediate Hepatocellular Carcinoma (HCC)
CompletedNCT03474354
Start: 2018-05-02End: 2022-01-05Updated: 2022-01-06
BioPearl™ Microspheres Loaded With Doxorubicin: Prospective, Single Arm, Multi-centre Post-market Follow-up Study.
WithdrawnNCT04231929
Start: 2020-05-31End: 2023-12-31Updated: 2022-03-28
Prevention and Treatment of Complications of Endovascular Methods in Patients With Malignant Liver Tumors
NCT04764409
Start: 2021-01-12End: 2023-12-12Target: 500Updated: 2021-02-21